Atlas Trials

Eloxx Pharmaceuticals, Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Eloxx Pharmaceuticals, Inc.

RecordFirmDate
EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety (NCT07523581)Eloxx Pharmaceuticals, Inc.2026-06-30
A Study of ELX-02 in Patients With Alport Syndrome (NCT05448755)Eloxx Pharmaceuticals, Inc.2022-11-28
A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD of ELX-02 in Cystic Fibrosis Patients With G542X Allele (NCT04135495)Eloxx Pharmaceuticals, Inc.2019-11-25
A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G542X Allele (NCT04126473)Eloxx Pharmaceuticals, Inc.2019-11-05
A Phase 2 Study of ELX-02 in Patients With Nephropathic Cystinosis (NCT04069260)Eloxx Pharmaceuticals, Inc.2019-08-02
A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02 (NCT03776539)Eloxx Pharmaceuticals, Inc.2019-01-04
Phase 1 Study of ELX-02 in Healthy Adult Subjects (NCT03309605)Eloxx Pharmaceuticals, Inc.2017-10-11
Phase 1 Study of ELX-02 in Healthy Adults (NCT03292302)Eloxx Pharmaceuticals, Inc.2017-09-26

Track Eloxx Pharmaceuticals, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.